Christine Lindsay Mummery

This inventor holds 8 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Es Cell International Pte Ltd, Academisch Ziekenhuis Leiden, Ncardia B.v.. Active years: 2012-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Lindsay Mummery. Retrieved from https://idiyas.com/inventor/christine-lindsay-mummery

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 62.5

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 26(Granted Patents)

Location History:

Bilthoven, NL (2012 - 2014)
DJ Bilthoven, NL (2012 - 2016)
Leiden, NL (2018 - 2020)

Company Filing History:

3 out of 24

Es Cell International Pte Ltd

patents

1 out of 47

Academisch Ziekenhuis Leiden

4. 3 out of 834,601

Other

patents

Years Active: 2012-2020

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10844354 - Cardiomyocyte maturation (2020-11-24),

2. 10119122 - Differentiation and expansion of endothelial cells from pluripotent stem cells and the in vitro formation of vasculature like structures (2018-11-06),

3. 9994822 - Cardiomyocyte differentiation (2018-06-12),

4. 9404085 - Direct differentiation of cardiomyocytes from embryonic stem cells (2016-08-02),

5. 9115343 - Cardiomyocyte differentiation (2015-08-25),

6. 8728457 - Methods of inducing differentiation of stem cells (2014-05-20),

7. 8318489 - Prostacyclin directed differentiation of cardiomyocytes from human embryonic stem cells (2012-11-27),

8. 8158421 - Cardiomyocyte differentiation (2012-04-17),

Title: Christine Lindsay Mummery: Innovator in Stem Cell Biology

Introduction

Christine Lindsay Mummery is a prominent inventor based in Bilthoven, Netherlands. She has made significant contributions to the fields of cell biology and molecular biology, particularly in stem cell research. With a total of eight patents to her name, Mummery is recognized for her innovative approaches to cardiomyocyte maturation and endothelial cell differentiation.

Latest Patents

Mummery's latest patents include groundbreaking work on cardiomyocyte maturation. This invention focuses on improving the maturity of stem cell-derived cardiomyocytes, specifically the ventricular type. The method enhances the upstroke velocity of these cells, which is crucial for their functionality. Another notable patent involves the differentiation and expansion of endothelial cells from pluripotent stem cells. This disclosure outlines methods for obtaining endothelial cells and creating vasculature-like structures in vitro, utilizing pericytes and smooth muscle cells derived from these stem cells.

Career Highlights

Throughout her career, Mummery has worked with various organizations, including Es Cell International Pte Ltd. Her research has significantly advanced the understanding of stem cell biology and its applications in regenerative medicine. Mummery's work has been instrumental in developing techniques that improve the functionality of stem cell-derived cells, paving the way for future innovations in the field.

Collaborations

Mummery has collaborated with notable scientists such as Robert Passier and Bruce Paul Davidson. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in stem cell applications.

Conclusion

Christine Lindsay Mummery is a trailblazer in the field of stem cell biology, with a focus on cardiomyocyte maturation and endothelial cell differentiation. Her contributions through patents and collaborations continue to influence the landscape of regenerative medicine.

Profile summary based on public USPTO records.